Systemic telomere length and preclinical atherosclerosis: the Asklepios Study.

@article{Meyer2009SystemicTL,
  title={Systemic telomere length and preclinical atherosclerosis: the Asklepios Study.},
  author={Tim de Meyer and Ernst R. Rietzschel and Marc L D De Buyzere and Michel R. Langlois and Dirk A De Bacquer and Patrick Segers and Piet Van Damme and Guy G. De Backer and Patrick M V Van Oostveldt and Wim van Criekinge and Thierry C Gillebert and Sofie Bekaert},
  journal={European heart journal},
  year={2009},
  volume={30 24},
  pages={3074-81}
}
AIMS Peripheral blood leucocyte (PBL) telomere length (TL) is a systemic ageing biomarker and has been proposed to be an independent predictor of cardiovascular disease (CVD). We aimed at providing an explanation for this association by the evaluation of the biomarker value of PBL-TL in preclinical atherosclerosis. METHODS AND RESULTS Peripheral blood… CONTINUE READING